IRF8 and acute lymphoblastic leukemia: Collectively, these results revealed the suppressive role of IRF8 in T‐ALL, and provide a new avenue of targeting epitranscriptomic modifying enzymes of IRF8 mRNA as a promising alternative therapeutic strategy to overcome T‐ALL.